(Q44066275)

29 November 2017

title

Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation (English)

1 reference

29 November 2017

Klumpp TR

1

1 reference

29 November 2017

Herman JH

2

1 reference

29 November 2017

Ulicny J

3

1 reference

29 November 2017

Emmons RV

4

1 reference

29 November 2017

Martin ME

5

1 reference

29 November 2017

Mangan KF

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

11 September 2006

1 reference

Bone Marrow Transplantation

29 November 2017

published in

1 reference

29 November 2017

volume

38

1 reference

29 November 2017

issue

9

1 reference

29 November 2017

page(s)

615-620

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705496

29 November 2017

exact match

0 references

cites work

RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant Hb level on transfusion and early survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

ABO blood group barrier in allogeneic bone marrow transplantation revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

What are the implications of optimism bias in clinical research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Presentation and subsequent publication rates of phase I oncology clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Systematic review of publication bias in studies on publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Fate of biomedical research protocols and publication bias in France: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Comparison of two methods to detect publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

The effect of minor ABO mismatches on the incidence of graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

Severe Delayed Hemolytic Transfusion Reaction Complicating an ABO-Incompatible Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Regeneration of peripheral blood cells following ABO incompatible allogeneic bone marrow transplantation for severe aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Risk factors for moderate-to-severe acute graft-vs.-host disease after allogeneic stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

ABH antigens and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

ABO-incompatible marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Publication bias and journals as policemen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Evidence of publication bias in clinical trials of biotherapies for solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

A risk score for mortality after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705496

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705496

1 reference

29 November 2017

1 reference